Understand the source comparison
Tesofensine Research Protocols: Dosing & Mechanism Comparison
Primary Mechanism Inhibits DAT, NET, and SERT simultaneously. Blocks reuptake of dopamine, norepinephrine, and serotonin at synaptic terminals Selective inhibitors target one transporter (e.g., SSRIs block SERT only; bupropion blocks DAT/NET) Mechanism preserv
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Primary Mechanism
- Inhibits DAT, NET, and SERT simultaneously. Blocks reuptake of dopamine, norepinephrine, and serotonin at synaptic terminals
- Selective inhibitors target one transporter (e.g., SSRIs block SERT only; bupropion blocks DAT/NET)
- Mechanism preserved only with intact molecular structure. Denaturation changes binding kinetics
- Triple inhibition requires stricter handling than single-target compounds due to structural complexity
- Typical Research Dose Range
- 0.25mg–1mg per administration in published studies (oral equivalent; injectable protocols may differ)
- Varies widely by compound (e.g., fluoxetine 20–80mg; bupropion 150–450mg)
- Dose precision depends on accurate reconstitution ratio and contamination-free multi-dose draws
- Lower absolute doses mean volumetric precision matters more. 0.1ml dosing error = 0.5mg variance at 5mg/ml concentration
- Solution Stability Post-Reconstitution
- 28 days at 2–8°C in bacteriostatic water
- SSRIs in solution: 30–90 days refrigerated; bupropion: 14 days
- Stability window shorter than many comparators due to triple-site molecular structure
- Plan experiments within 28-day window. Extended storage invalidates potency assumptions
- Temperature Sensitivity
- Denatures above 8°C; lyophilised powder stable at −20°C
- Most monoamine inhibitors tolerate brief room-temperature exposure (e.g., 24–48 hours)
- Requires dedicated cold storage with temperature monitoring
- More sensitive than standard SSRIs. Household refrigerator acceptable if temp-monitored
- Contamination Risk (Multi-Dose)
- High. Benzyl alcohol in bacteriostatic water inhibits but doesn't sterilise; 10+ draws per vial = 10 contamination events
- Equivalent for any multi-dose injectable peptide or compounded medication
- Swab stopper with 70% isopropyl before every draw; use sterile needle each time
- Standard aseptic technique applies. Tesofensine-specific risk is duration (28 days = more draws = more contamination opportunities)